Kegg medicus dgroup en
| DG02886 | |
| DG number | DG02886 |
| Classification | DGroup |
| Name | CYP2C9 inducer TYPE Metabolism |
| Stem | - |
| Structural formula |  |
| Member | DG00066 Aprepitant D02968 Aprepitant (JAN/USP/INN) D10895 Fosaprepitant (INN) D06597 Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN) DG00266 Bosentan D07538 Bosentan (INN) D01227 Bosentan (USAN); Bosentan hydrate (JAN) D00879 Rifapentine (USAN/INN) D00427 Ritonavir (JAN/USP/INN) D10801 Letermovir (JAN/USAN/INN) DG00721 Dabrafenib D10064 Dabrafenib (USAN) D10104 Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN) D11040 Apalutamide (JAN/INN) DG00845 Phenobarbital D00506 Phenobarbital (JP18/USP/INN) D00701 Phenobarbital sodium (JAN/USP/INN) D08356 Phenobarbital diethylamine |
| Upper group | Metabolizing enzyme inducer |
| Remark | - |
| Comment | - |